Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah R. Shatzkes is active.

Publication


Featured researches published by Deborah R. Shatzkes.


Otolaryngologic Clinics of North America | 2012

Masticator space: imaging anatomy for diagnosis.

Daniel E. Meltzer; Deborah R. Shatzkes

Masticator space anatomy and pathologic conditions are illustrated examples from computed tomography and magnetic resonance imaging. Characteristic imaging features of various disease processes are presented to aid the otolaryngologist (head and neck surgeon) in diagnosis. The article describes infection, primary neoplasm, metastatic disease, Osteonecrosis, and vascular anomalies.


Otolaryngology-Head and Neck Surgery | 2017

Clinical Practice Guideline: Evaluation of the Neck Mass in Adults:

Melissa A. Pynnonen; M. Boyd Gillespie; Benjamin R. Roman; Richard M. Rosenfeld; David E. Tunkel; Laura J. Bontempo; Itzhak Brook; Davoren A. Chick; Maria Colandrea; Sandra A. Finestone; Jason C. Fowler; Christopher C. Griffith; Zeb Henson; Corinna G. Levine; Vikas Mehta; Andrew Salama; Joseph Scharpf; Deborah R. Shatzkes; Wendy B. Stern; Jay S. Youngerman; Maureen D. Corrigan

Objective Neck masses are common in adults, but often the underlying etiology is not easily identifiable. While infections cause most of the neck masses in children, most persistent neck masses in adults are neoplasms. Malignant neoplasms far exceed any other etiology of adult neck mass. Importantly, an asymptomatic neck mass may be the initial or only clinically apparent manifestation of head and neck cancer, such as squamous cell carcinoma (HNSCC), lymphoma, thyroid, or salivary gland cancer. Evidence suggests that a neck mass in the adult patient should be considered malignant until proven otherwise. Timely diagnosis of a neck mass due to metastatic HNSCC is paramount because delayed diagnosis directly affects tumor stage and worsens prognosis. Unfortunately, despite substantial advances in testing modalities over the last few decades, diagnostic delays are common. Currently, there is only 1 evidence-based clinical practice guideline to assist clinicians in evaluating an adult with a neck mass. Additionally, much of the available information is fragmented, disorganized, or focused on specific etiologies. In addition, although there is literature related to the diagnostic accuracy of individual tests, there is little guidance about rational sequencing of tests in the course of clinical care. This guideline strives to bring a coherent, evidence-based, multidisciplinary perspective to the evaluation of the neck mass with the intention to facilitate prompt diagnosis and enhance patient outcomes. Purpose The primary purpose of this guideline is to promote the efficient, effective, and accurate diagnostic workup of neck masses to ensure that adults with potentially malignant disease receive prompt diagnosis and intervention to optimize outcomes. Specific goals include reducing delays in diagnosis of HNSCC; promoting appropriate testing, including imaging, pathologic evaluation, and empiric medical therapies; reducing inappropriate testing; and promoting appropriate physical examination when cancer is suspected. The target patient for this guideline is anyone ≥18 years old with a neck mass. The target clinician for this guideline is anyone who may be the first clinician whom a patient with a neck mass encounters. This includes clinicians in primary care, dentistry, and emergency medicine, as well as pathologists and radiologists who have a role in diagnosing neck masses. This guideline does not apply to children. This guideline addresses the initial broad differential diagnosis of a neck mass in an adult. However, the intention is only to assist the clinician with a basic understanding of the broad array of possible entities. The intention is not to direct management of a neck mass known to originate from thyroid, salivary gland, mandibular, or dental pathology as management recommendations for these etiologies already exist. This guideline also does not address the subsequent management of specific pathologic entities, as treatment recommendations for benign and malignant neck masses can be found elsewhere. Instead, this guideline is restricted to addressing the appropriate work-up of an adult patient with a neck mass that may be malignant in order to expedite diagnosis and referral to a head and neck cancer specialist. The Guideline Development Group sought to craft a set of actionable statements relevant to diagnostic decisions made by a clinician in the workup of an adult patient with a neck mass. Furthermore, where possible, the Guideline Development Group incorporated evidence to promote high-quality and cost-effective care. Action Statements The development group made a strong recommendation that clinicians should order a neck computed tomography (or magnetic resonance imaging) with contrast for patients with a neck mass deemed at increased risk for malignancy. The development group made the following recommendations: (1) Clinicians should identify patients with a neck mass who are at increased risk for malignancy because the patient lacks a history of infectious etiology and the mass has been present for ≥2 weeks without significant fluctuation or the mass is of uncertain duration. (2) Clinicians should identify patients with a neck mass who are at increased risk for malignancy based on ≥1 of these physical examination characteristics: fixation to adjacent tissues, firm consistency, size >1.5 cm, or ulceration of overlying skin. (3) Clinicians should conduct an initial history and physical examination for patients with a neck mass to identify those with other suspicious findings that represent an increased risk for malignancy. (4) For patients with a neck mass who are not at increased risk for malignancy, clinicians or their designees should advise patients of criteria that would trigger the need for additional evaluation. Clinicians or their designees should also document a plan for follow-up to assess resolution or final diagnosis. (5) For patients with a neck mass who are deemed at increased risk for malignancy, clinicians or their designees should explain to the patient the significance of being at increased risk and explain any recommended diagnostic tests. (6) Clinicians should perform, or refer the patient to a clinician who can perform, a targeted physical examination (including visualizing the mucosa of the larynx, base of tongue, and pharynx) for patients with a neck mass deemed at increased risk for malignancy. (7) Clinicians should perform fine-needle aspiration (FNA) instead of open biopsy, or refer the patient to someone who can perform FNA, for patients with a neck mass deemed at increased risk for malignancy when the diagnosis of the neck mass remains uncertain. (8) For patients with a neck mass deemed at increased risk for malignancy, clinicians should continue evaluation of patients with a cystic neck mass, as determined by FNA or imaging studies, until a diagnosis is obtained and should not assume that the mass is benign. (9) Clinicians should obtain additional ancillary tests based on the patient’s history and physical examination when a patient with a neck mass is deemed at increased risk for malignancy who does not have a diagnosis after FNA and imaging. (10) Clinicians should recommend evaluation of the upper aerodigestive tract under anesthesia, before open biopsy, for patients with a neck mass deemed at increased risk for malignancy and without a diagnosis or primary site identified with FNA, imaging, and/or ancillary tests. The development group recommended against clinicians routinely prescribing antibiotic therapy for patients with a neck mass unless there are signs and symptoms of bacterial infection.


Radiology | 2009

Case 152: Orbital Metastatic Disease from Breast Carcinoma

Daniel E. Meltzer; Albert H. Y. Chang; Deborah R. Shatzkes

Bilateral orbital disease with enophthalmos in a woman is virtually pathognomonic for metastatic breast cancer, with a scirrhous fibrotic process accounting for ocular retraction.


Otolaryngology-Head and Neck Surgery | 2017

Clinical Practice Guideline: Evaluation of the Neck Mass in Adults Executive Summary

Melissa A. Pynnonen; M. Boyd Gillespie; Benjamin R. Roman; Richard M. Rosenfeld; David E. Tunkel; Laura J. Bontempo; Itzhak Brook; Davoren A. Chick; Maria Colandrea; Sandra A. Finestone; Jason C. Fowler; Christopher C. Griffith; Zeb Henson; Corinna G. Levine; Vikas Mehta; Andrew Salama; Joseph Scharpf; Deborah R. Shatzkes; Wendy B. Stern; Jay S. Youngerman; Maureen D. Corrigan

The American Academy of Otolaryngology—Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the “Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.” To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 12 recommendations developed emphasize reducing delays in diagnosis of head and neck squamous cell carcinoma; promoting appropriate testing, including imaging, pathologic evaluation, and empiric medical therapies; reducing inappropriate testing; and promoting appropriate physical examination when cancer is suspected.


Clinical Nuclear Medicine | 2008

Asymmetric I-131 uptake in the submandibular gland in the setting of thyroid carcinoma.

Daniel E. Meltzer; Nathalie V. Gebara; Sumina Goel; Munir Ghesani; Daniel B. Kuriloff; Deborah R. Shatzkes

I-131 scans may demonstrate asymmetric submandibular signal, secondary to physiologic or pathophysiologic processes. CT correlation may help distinguish metastatic lymphadenopathy from other causes of abnormal uptake. In this report, 2 patients with history of thyroid carcinoma underwent follow-up I-131 scintigraphy. Asymmetric submandibular uptake led to further evaluation with CT. In both cases, the asymmetric uptake was related to alterations of normal physiologic uptake and excretion in the submandibular gland, by different mechanisms. In the first case, excretion was impaired because of chronic obstruction. In the second case, asymmetry was due to chronic disease with impaired function on the contralateral side.


Otolaryngologic Clinics of North America | 2018

Imaging of Vascular Lesions of the Head and Neck

Jared M. Steinklein; Deborah R. Shatzkes

This article provides an overview of imaging findings of common and uncommon vascular lesions in the head and neck and showcases images highlighting imaging findings. Both hemangiomas and vascular malformations are covered.


Archives of Otolaryngology-head & Neck Surgery | 2017

Trismus and Swelling on the Side of the Face

Matthew E. Maeder; David L. Hirsch; Deborah R. Shatzkes

A woman in her 60s presented with mild to moderate trismus and swelling on the left side of the face of a few months’ duration. Her medical history was significant for herpes zoster and self-limited vertigo approximately 3 years prior. Her physical examination was remarkable for left-sided facial swelling. No deficits of the facial or trigeminal nerves were detected. Magnetic resonance imaging (MRI) was performed (Figure). T1-weighted image A


Archives of Otolaryngology-head & Neck Surgery | 2014

A Rare Sinonasal Entity

Pooja H. Doshi; Benjamin R. Roman; Jessica W. Lim; Deborah R. Shatzkes

Awoman in her 70swith a history of radiation therapy for a nasal cavity lymphoma15yearspriorpresentedwithcomplaintsofchronic right nasal obstruction and right epiphora. She denied epistaxis or pain. She described having undergone 2 surgical procedures in the interim for occluded nasolacrimal duct, at 1 year and 8 years after treatment. Onnasalendoscopy,asmooth,pink, friablemasswasseenabutting the posterior aspect of the right inferior turbinate and extending to fill most of the nasopharynx. This mass was visible through the left choana as well. There was also an erythematous irregular area, smaller than 1 cm, on the right lateral nasal wall, correspondingtotheorificeof thenasolacrimalduct.Themiddle turbinateswere intact, andnoother lesionswere seen.Theoropharynxandoral cavity were clear, and findings from fiber-optic laryngoscopy was normal. Orbital examination revealed right epiphora without additional abnormality. Maxillofacial computed tomographic (CT) imaging along with a magnetic resonance imaging (MRI) of the head were performed. Coronal CT image with bone window (Figure, A), sagittal T1weighted imagewithout contrast (Figure, B), coronal T2-weighted (Figure, C), and contrast-enhanced, fat-saturated, T1-weighted (Figure,D) imagesarepresented for interpretation.Thepatientwas brought to the operating room for biopsy. What is your diagnosis? A


Seminars in Ultrasound Ct and Mri | 2012

Imaging of the Parathyroid Glands

C. Douglas Phillips; Deborah R. Shatzkes


Radiology | 2006

Sclerosis of the pterygoid process in untreated patients with nasopharyngeal carcinoma.

Deborah R. Shatzkes; Daniel E. Meltzer; Jane A. Lee; James S. Babb; Nicholas J. Sanfilippo; Roy A. Holliday

Collaboration


Dive into the Deborah R. Shatzkes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge